← All stocks

Emergent BioSolutions Inc.

EBS No buying or selling
CIK 0001367644 #3771 in the set updated 20 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
$0.00
$0.00 against sales at will

By person

17 insiders · 0 transactions
3.9×

Joseph Papa holds only 3.9 times base salary in stock. $4.14M of shares against $1.04M in salary for 2025.

Salary from the company's own proxy. The shares are what Joseph Papa last reported holding, valued at $8.40, the price Common Stock was last bought or sold at on the open market here, on 1 Jul 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
PAPA JOSEPH C
President and CEO
493,153
$4.14M
LINDAHL RICHARD S
EVP, Chief Financial Officer
374,083
$3.14M
+139.8%
Glessner Coleen
EVP, Quality & Ethics, and CPL
202,201
$1.70M
+23.9%
Hartzel William
SVP, Bioservices
185,558
$1.56M
+285.7%
Lowry Simon C
SVP, R&D, CMO
177,914
$1.49M
Perl Jessica
SVP, General Counsel, Corp Sec
165,286
$1.39M
+2,329%
Fowler Neal Franklin
Director
160,847
$1.35M
+18.2%
Williams Paul Anthony
SVP, Products Business
159,098
$1.34M
+553.8%
Harsanyi Zsolt
Chairman
149,076
$1.25M
+66.9%
SULLIVAN LOUIS W
Director
139,098
$1.17M
+32.9%
DeGolyer Donald W
Director
129,721
$1.09M
−4.7%
Richard Ronald
Director
123,761
$1.04M
+74.0%
White Marvin L
Director
113,839
$956.25K
+66.5%
Dayal Sujata Tyagi
Director
100,563
$844.73K
+59.3%
Katkin Keith
Director
96,294
$808.87K
+60.8%
Zoon Kathryn C
Director
79,941
$671.50K
+46.7%
FOWLER JOHN D JR
Director
30,350
$254.94K

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 0
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 0
History held since 10 Nov 2016